Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/09/2007WO2007089043A1 Liposome preparation
08/09/2007WO2007089034A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
08/09/2007WO2007089031A1 Piperidine derivatives as tachykinin receptor antagonists
08/09/2007WO2007089030A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088999A1 Trisubstituted amine compound
08/09/2007WO2007088996A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
08/09/2007WO2007088960A1 Anti-fatigue composition
08/09/2007WO2007088900A1 Double-stranded rna inducing cell death
08/09/2007WO2007088895A1 3-arylamino-1,2,4-triazole derivative
08/09/2007WO2007088869A1 Method for producing denatured substance of lactalbumin
08/09/2007WO2007088712A1 Neuronal cell death inhibitor and screening method
08/09/2007WO2007088705A1 Remedy for diabetic
08/09/2007WO2007088704A1 Preventive/remedy for urinary calculosis
08/09/2007WO2007088651A1 JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT
08/09/2007WO2007088554A1 A pharmaceutical composition for treatment of vulnerable atherosclerotic plaque and inhibition of thrombosis, adhesion molecules and inflammation
08/09/2007WO2007088528A1 Microtubule targeting agents
08/09/2007WO2007088514A1 Secondary amines as renin inhibitors
08/09/2007WO2007088483A1 Amorphous and crystalline forms of aprepitant and processes for the preparation thereof
08/09/2007WO2007088478A1 Indazole oxazolidinones as antibacterial agents
08/09/2007WO2007088473A2 Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
08/09/2007WO2007088462A1 Spirochromane antagonists of the h-3 receptor
08/09/2007WO2007088450A2 Chromane antagonist of the h-3 receptor
08/09/2007WO2007088438A2 Benzisoxazole oxazolidinones as antibacterial agents
08/09/2007WO2007088421A2 A process for the removal of sterols and other compounds from glycerol oils
08/09/2007WO2007088408A1 A method of curing antibiotic resistant plasmids
08/09/2007WO2007088401A1 Indazole derivatives for treatment of alzheimer's disease
08/09/2007WO2007088400A1 Identification of compounds suitable for treating ad
08/09/2007WO2007088345A1 Thieno-pyridine derivatives as mek inhibitors
08/09/2007WO2007088277A1 Tricyclic ν-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
08/09/2007WO2007088214A2 Treating hiv infection, wherein hiv has a k65r mutation
08/09/2007WO2007088196A1 Use of alkylglucoside esters as beta-defensin inducers
08/09/2007WO2007088190A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007WO2007088189A1 Benzoisoindole derivatives for the treatment of pain
08/09/2007WO2007088181A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
08/09/2007WO2007088159A1 Methods of treating degenerative disorders with rac 1b inhibitor
08/09/2007WO2007088148A1 Derivatives of thiophene carboxilic acid as antiviral agent
08/09/2007WO2007088123A2 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
08/09/2007WO2007088063A1 Acid addition salts of n-{3-[4-(2-methoxyphenyl)-l-piperazinyl]-propyl}-7-oxo-5- trifluoromethyl-7h-thieno[3,2-b]pyran-3-carboxamide
08/09/2007WO2007088050A2 Method of treatment for muscular dystrophy
08/09/2007WO2007088041A1 Compounds for the inhibition of integrins and use thereof
08/09/2007WO2007088035A1 A pharmaceutical composition comprising perindopril
08/09/2007WO2007088034A2 Tuberous sclerosis treatment
08/09/2007WO2007088019A1 Use of naphthyridine derivatives as medicaments
08/09/2007WO2007088014A1 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
08/09/2007WO2007087872A1 Transdermal therapeutic system for volatile and/or thermolabile substances
08/09/2007WO2007087806A1 A topical composition comprising an antibacterial substance
08/09/2007WO2007087722A1 Use of soy kefir powder for reducing pain, blood pressure and inflammation
08/09/2007WO2007087717A1 Viral polymerase inhibitors
08/09/2007WO2007087700A1 Process for the preparation of formulations of angiotensin converting enzyme inhibitors and product
08/09/2007WO2007087684A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/09/2007WO2007087667A2 Combination preparation for improving sperm quality
08/09/2007WO2007072080A3 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
08/09/2007WO2007071970A3 Combination of azd2171 and pemetrexed
08/09/2007WO2007071965A3 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
08/09/2007WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
08/09/2007WO2007071840A3 Compounds based on four aromatic rings, preparation and uses thereof
08/09/2007WO2007071444A3 Esomeprazole arginine
08/09/2007WO2007071205A3 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
08/09/2007WO2007064872A3 Urea compounds useful in the treatment of cancer
08/09/2007WO2007064772A3 Implantable microbial cellulose materials for various medical applications
08/09/2007WO2007062875B1 Heteroaromatic sulfonamide prodrugs
08/09/2007WO2007060512A3 Compositions containing topical active agents and pentylene glycol
08/09/2007WO2007059952A3 1-benzazepine-3-sulfonylamino-2-pyrrloridones as factor xa inhibitors
08/09/2007WO2007059202A3 Pyrazolyl urea derivatives useful in the treatment of cancer
08/09/2007WO2007055941A3 Histone deacetylase inhibitors with aryl-pyrazolyl motifs
08/09/2007WO2007054968A3 Novel pharmaceutical compositions of clopidogrel mesylate
08/09/2007WO2007054725A3 Combination of a cdk-inhibitor and a hdac-inhibitor
08/09/2007WO2007054520A3 Methods for the identification of microrna and their applications in research and human health
08/09/2007WO2007054283A3 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/09/2007WO2007053343A3 Compounds and compositions as protein kinase inhibitors
08/09/2007WO2007053194A3 Modulation of cell barrier dysfunction
08/09/2007WO2007052164A3 A pharmaceutical formulation containing olanzapine
08/09/2007WO2007050513A3 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity
08/09/2007WO2007047978A3 Modulation of neurogenesis by pde inhibition
08/09/2007WO2007047744A3 Method for treating primary and secondary forms of glaucoma
08/09/2007WO2007047473A3 Methods of administering rapamycin analogs with anti-inflammatories using medical devices
08/09/2007WO2007047397A3 Phenol ethers as modulators of the opioid receptors
08/09/2007WO2007044729A3 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
08/09/2007WO2007041637A3 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
08/09/2007WO2007039760A3 Use of oligouronates for treating mucus hyperviscosity
08/09/2007WO2007039533A3 Antifungal composition
08/09/2007WO2007038444A3 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
08/09/2007WO2007030302A3 Drugs coated on a device to treat vulnerable plaque
08/09/2007WO2007030153A3 Compositions containing micronized tanaproget
08/09/2007WO2007024843A3 Pyrimidinyl-pyrazole inhibitors of aurora kinases
08/09/2007WO2007024338A3 3 -ester prodrugs of ethynylestradiol
08/09/2007WO2007022924A3 Pharmaceutical compositions with melting point depressant agents and method of making same
08/09/2007WO2007021990A3 Melanocortin receptor-specific piperazine compounds with diamine groups
08/09/2007WO2007021805A3 Estrogen compositions and therapeutic methods of use thereof
08/09/2007WO2007021754A3 Diltiazem controlled release formulation and method of manufacture
08/09/2007WO2007010509A3 Controlled release pharmaceutical composition comprising alpha-adrenergic antagonist and muscarinic antagonist
08/09/2007WO2007008548A3 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
08/09/2007WO2007006036A3 Hydroxylated forms of ergosterols and ergocalciferols, derivatives thereof, methods of production and uses thereof
08/09/2007WO2007002823A3 Formulations of conjugated estrogens and bazedoxifene
08/09/2007WO2006128639A3 Process for the preparation and isolation of phosphatides
08/09/2007WO2006127044A3 Pharmaceutical formulations useful for inhibiting acid secretion
08/09/2007WO2006125048A3 Hiv-integrase inhibitor compounds
08/09/2007WO2006122217A3 Supersaturated benzodiazepine solutions and their delivery
08/09/2007WO2006117217A3 Novel use of spiegelmers
1 ... 3631 3632 3633 3634 3635 3636 3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 3650 3651 ... 7860